# FDA Inspection 1120265 - LILLY CENTRE FOR CLINICAL PHARMACOLOGY PTE LTD - February 07, 2020

Source: https://www.keypedia.com/records/fda_inspections/lilly-centre-for-clinical-pharmacology-pte-ltd/a8e24002-0949-419f-92cd-ead9bddcc190
Source feed: FDA_Inspections

> FDA Inspection 1120265 for LILLY CENTRE FOR CLINICAL PHARMACOLOGY PTE LTD on February 07, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1120265
- Company Name: LILLY CENTRE FOR CLINICAL PHARMACOLOGY PTE LTD
- Inspection Date: 2020-02-07
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/lilly-centre-for-clinical-pharmacology-pte-ltd/f49c6194-09d6-4717-a37c-f2c730a546d4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c